Design Therapeutics hints at ‘strategic realignment,’ replaces CEO; Karyopharm co-founder leads ATP’s Nereid

Pratik Shah

Design Therapeutics chairman Pratik Shah has succeeded João Siffert as CEO while teasing a “strategic realignment” that won’t be revealed until early 2024, according to its Q3 report. Design does elaborate on the status of its cash runway,…
Click here to view original post